Frontage Holdings (HKSE:01521) 5-Year EBITDA Growth Rate : 12.30% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings 5-Year EBITDA Growth Rate?

Frontage Holdings's EBITDA per Share for the six months ended in Dec. 2024 was HK$0.03.

During the past 12 months, Frontage Holdings's average EBITDA Per Share Growth Rate was -11.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 0.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Frontage Holdings was 37.60% per year. The lowest was 0.20% per year. And the median was 23.80% per year.

Competitive Comparison of Frontage Holdings's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Frontage Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontage Holdings's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Frontage Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Frontage Holdings (HKSE:01521) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Frontage Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontage Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Pennsylvania Drive, Exton, PA, USA, 19341

Website

https://www.frontagelab.com

Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world.

Executives

Hongkong Tigermed Co., Limited
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si	2101 Beneficial owner
Li Song	2101 Beneficial owner
Kabouter Management Llc	2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.

Frontage Holdings Headlines

No Headlines